1
|
Di Minno A, Frigerio B, Spadarella G, Ravani A, Sansaro D, Amato M, Kitzmiller JP, Pepi M, Tremoli E, Baldassarre D. Old and new oral anticoagulants: Food, herbal medicines and drug interactions. Blood Rev 2017; 31:193-203. [PMID: 28196633 DOI: 10.1016/j.blre.2017.02.001] [Citation(s) in RCA: 134] [Impact Index Per Article: 19.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2016] [Accepted: 02/02/2017] [Indexed: 12/21/2022]
Abstract
The most commonly prescribed oral anticoagulants worldwide are the vitamin K antagonists (VKAs) such as warfarin. Factors affecting the pharmacokinetics of VKAs are important because deviations from their narrow therapeutic window can result in bleedings due to over-anticoagulation or thrombosis because of under-anticoagulation. In addition to pharmacodynamic interactions (e.g., augmented bleeding risk for concomitant use of NSAIDs), interactions with drugs, foods, herbs, and over-the-counter medications may affect the risk/benefit ratio of VKAs. Direct oral anticoagulants (DOACs) including Factor Xa inhibitors (rivaroxaban, apixaban and edoxaban) and thrombin inhibitor (dabigatran) are poised to replace warfarin. Phase-3 studies and real-world evaluations have established that the safety profile of DOACs is superior to those of VKAs. However, some pharmacokinetic and pharmacodynamic interactions are expected. Herein we present a critical review of VKAs and DOACs with focus on their potential for interactions with drugs, foods, herbs and over-the-counter medications.
Collapse
Affiliation(s)
| | | | - Gaia Spadarella
- Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli "Federico II", Naples, Italy.
| | | | | | - Mauro Amato
- Centro Cardiologico Monzino, IRCCS, Milan, Italy.
| | | | - Mauro Pepi
- Centro Cardiologico Monzino, IRCCS, Milan, Italy.
| | - Elena Tremoli
- Centro Cardiologico Monzino, IRCCS, Milan, Italy; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
| | - Damiano Baldassarre
- Centro Cardiologico Monzino, IRCCS, Milan, Italy; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
| |
Collapse
|
2
|
Dias MFRG, Bernardes-Filho F, Quaresma-Santos MVP, Amorim AGDF, Schechtman RC, Azulay DR. Treatment of superficial mycoses: review. Part II. An Bras Dermatol 2014; 88:937-44. [PMID: 24474103 PMCID: PMC3900345 DOI: 10.1590/abd1806-4841.20132018] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2012] [Accepted: 12/11/2012] [Indexed: 05/28/2023] Open
Abstract
Superficial fungal infections of the hair, skin and nails are a major cause of
morbidity in the world. Choosing the right treatment is not always simple because of
the possibility of drug interactions and side effects. The first part of the article
discusses the main treatments for superficial mycoses - keratophytoses,
dermatophytosis, candidiasis, with a practical approach to the most commonly-used
topical and systemic drugs , referring also to their dosage and duration of use.
Promising new, antifungal therapeutic alternatives are also highlighted, as well as
available options on the Brazilian and world markets.
Collapse
Affiliation(s)
- Maria Fernanda Reis Gavazzoni Dias
- Prof. Rubem David Azulay Dermatology Institute, Santa Casa da Misericórdia do Rio de Janeiro, Rio de JaneiroRJ, Brazil, MD, PhD, Professor of the Post-Graduation program at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil
| | - Fred Bernardes-Filho
- Prof. Rubem David Azulay Dermatology Institute, Santa Casa da Misericórdia do Rio de Janeiro, Rio de JaneiroRJ, Brazil, MD, Post-graduation in course at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil
| | - Maria Victória Pinto Quaresma-Santos
- Prof. Rubem David Azulay Dermatology Institute, Santa Casa da Misericórdia do Rio de Janeiro, Rio de JaneiroRJ, Brazil, MD, Post-graduation in course at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil
| | | | - Regina Casz Schechtman
- London University, MD, PhD in Dermatology at London University. Coordinator of the Dermatology post-graduation program and chief of the mycology sector at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil
| | - David Rubem Azulay
- Dermatology Service, Prof. Rubem David Azulay Dermatology Institute, Santa Casa da Misericórdia do Rio de Janeiro, Rio de JaneiroRJ, Brazil, MD, MSc, Chief of the Dermatology Service at Prof. Rubem David Azulay Dermatology Institute at Santa Casa da Misericórdia do Rio de Janeiro (IDPRDA -SCMRJ) - Rio de Janeiro (RJ), Brazil. Chair Professor of the Post-graduation Program at Rio de Janeiro Pontifical Catholic University (PUC-RJ). Professor at Souza Marques Foundation and Rio de Janeiro Federal University (UFRJ) - Rio de Janeiro (RJ), Brazil
| |
Collapse
|
3
|
Interaction between ciclopirox and acenocoumarol. Eur J Clin Pharmacol 2012; 69:727-8. [PMID: 22791274 DOI: 10.1007/s00228-012-1347-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2012] [Accepted: 06/25/2012] [Indexed: 10/28/2022]
|